⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2182183 | 1.00 | — | — | |
| SCHEMBL1467724 | 1.00 | — | — | |
| SCHEMBL1081706 | 1.00 | — | — | |
| SCHEMBL6573684 | 1.00 | — | — | |
| SCHEMBL3830467 | 1.00 | — | — | |
| SCHEMBL2033291 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL7701941 | 0.98 | CYP2C19 (0.46) | — | |
| Hydrochloric Acid SCHEMBL7701945 | 0.98 | CYP2C19 (0.46) | — | |
| Hydrochloric Acid SCHEMBL21874191 | 0.98 | CYP2C19 (0.46) | — | |
| Hydrochloric Acid SCHEMBL14893315 | 0.98 | CYP2C19 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4511368-A2 | CCR4 ANTAGONISTS | ChemoCentryx, Inc. (US) | 2025-02-26 | — | — | EP | disclosed |
| US-20230382894-A1 | CCR4 ANTAGONISTS | CHEMOCENTRYX, INC. | 2023-11-30 | — | — | US | disclosed |
| WO-2023205618-A2 | CCR4 ANTAGONISTS | CHEMOCENTRYX, INC. (US) | 2023-10-26 | — | — | WO | disclosed |